Tools

LEADER 03063cam a2200529Ma 4500

001 ocn880305929;

003 OCoLC;

005 20221026170156.0;

008 120725s2012 enka b 001 0 eng d;

020 a| 9781849731669;

020 a| 1849731667;

035 a| (Sirsi) o880305929;

035 a| (OCoLC)880305929;

049 a| EREE;

082 04 a| 615.192| 23;

090 a| QV744b| D794 2012;

245 00 a| Drug design strategies :b| quantitative approaches /c| edited by David J. Livingstone, Andrew M. Davis.;

250 a| 1st ed.;

300 a| xvii, 498 pages :b| illustrations ;c| 25 cm.;

336 a| textb| txt2| rdacontent;

337 a| unmediatedb| n2| rdamedia;

338 a| volumeb| nc2| rdacarrier;

490 1 a| RSC drug discovery series ;v| no. 13;

504 a| Includes bibliographical references and index.;

505 00 g| The evoluation of quantitative drug design --t| Drug-like physicochemical properties --t| Development of QSAR --t| The development of molecular modelling programs: the use and limitations of physical models --t| Contribution of structure-based drug design to the discovery of marketed drugs --t| Representing chemical structures in databases for drug design --t| Modeling chemical structural-log P --t| Characterising chemical structure using physicochemical descriptors --t| Assessing quantitative model quality and performance --t| Application of modeling techniques --t| Expert systems: the use of expert systems in drug design-toxicity and metabolism --t| Ligand-based modeling of toxicity --t| ADME(T) predictions in drug discovery --t| Design of chemical libraries --t| The impact of genomics, systems biology, and bioinformatics on drug and target discovery: challenge and opportunity --t| Scoring drug-receptor interactions --t| Modelling chemicals in the environment.;

650 0 a| Drugsx| Design.=| ^A477567;

650 0 a| QSAR (Biochemistry)=| ^A373586;

650 0 a| Chemical models.=| ^A94862;

650 0 a| Decision makingx| Mathematical models.=| ^A18292;

650 2 a| Drug Design0| (DNLM)D015195=| ^A925973;

650 2 a| Drug Discovery0| (DNLM)D055808=| ^A1013013;

650 2 a| Quantitative Structure-Activity Relationship0| (DNLM)D021281=| ^A941076;

650 2 a| Models, Molecular0| (DNLM)D008958=| ^A933130;

650 2 a| Models, Chemical0| (DNLM)D008956=| ^A920876;

650 2 a| Decision Support Techniques0| (DNLM)D003661=| ^A925798;

650 7 a| Drugsx| Design.2| fast0| (OCoLC)fst00898790;

700 1 a| Livingstone, D.q| (David),e| editor.=| ^A1444918;

700 1 a| Davis, Andrew M.c| (Chemist),e| editor.=| ^A1444228;

710 2 a| Royal Society of Chemistry (Great Britain)=| ^A634689;

830 0 a| RSC drug discovery series ;v| no. 13.=| ^A1121214;

949 a| QV744 .D794 2012h| Joyner48i| 30372017532877o| jwjh;

994 a| C0b| ERE;

596 a| 1;

998 a| 5888404;

999 a| QV744 .D794 2012w| LCc| 1i| 30372017532877l| JGESm| JOYNERr| Ys| Yt| JGESBKu| 8/22/2022x| BOOKz| JSTACKSo| .STAFF. jwjh;

Drug design strategies : quantitative approaches / edited by David J. Livingstone, Andrew M. Davis.

Other author	Livingstone, D. (David), editor.
Other author	Davis, Andrew M. (Chemist), editor.
Other author	Royal Society of Chemistry (Great Britain)
Format	Book
Edition	1st ed.
Publication Info	Cambridge : Royal Society of Chemistry, ©2012.
Description	xvii, 498 pages : illustrations ; 25 cm.
Subjects	Drugs--Design. QSAR (Biochemistry) Chemical models. Decision making--Mathematical models. Drug Design Drug Discovery Quantitative Structure-Activity Relationship Models, Molecular Models, Chemical Decision Support Techniques

Series	RSC drug discovery series ; no. 13 RSC drug discovery series ; no. 13. ^A1121214
Contents	The evoluation of quantitative drug design -- Drug-like physicochemical properties -- Development of QSAR -- The development of molecular modelling programs: the use and limitations of physical models -- Contribution of structure-based drug design to the discovery of marketed drugs -- Representing chemical structures in databases for drug design -- Modeling chemical structural-log P -- Characterising chemical structure using physicochemical descriptors -- Assessing quantitative model quality and performance -- Application of modeling techniques -- Expert systems: the use of expert systems in drug design-toxicity and metabolism -- Ligand-based modeling of toxicity -- ADME(T) predictions in drug discovery -- Design of chemical libraries -- The impact of genomics, systems biology, and bioinformatics on drug and target discovery: challenge and opportunity -- Scoring drug-receptor interactions -- Modelling chemicals in the environment.
Bibliography note	Includes bibliographical references and index.
ISBN	9781849731669
ISBN	1849731667

Availability

Library	Location	Call Number	Status	Item Actions
Joyner	General Stacks	QV744 .D794 2012	✔ Available	Place Hold

Drug design strategies : quantitative approaches / edited by David J. Livingstone, Andrew M. Davis.

Click here for more information about this title

Availability